482 related articles for article (PubMed ID: 23026979)
1. Neuroprotection and repair in multiple sclerosis.
Franklin RJ; ffrench-Constant C; Edgar JM; Smith KJ
Nat Rev Neurol; 2012 Nov; 8(11):624-34. PubMed ID: 23026979
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis - remyelination failure as a cause of disease progression.
Hagemeier K; Brück W; Kuhlmann T
Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
[TBL] [Abstract][Full Text] [Related]
3. Evidence for neuroprotection and remyelination using imaging techniques.
Arnold DL
Neurology; 2007 May; 68(22 Suppl 3):S83-90; discussion S91-6. PubMed ID: 17548574
[TBL] [Abstract][Full Text] [Related]
4. Remyelinating and neuroprotective treatments in multiple sclerosis.
Stangel M
Expert Opin Investig Drugs; 2004 Apr; 13(4):331-47. PubMed ID: 15102584
[TBL] [Abstract][Full Text] [Related]
5. Overcoming remyelination failure in multiple sclerosis and other myelin disorders.
Fancy SP; Kotter MR; Harrington EP; Huang JK; Zhao C; Rowitch DH; Franklin RJ
Exp Neurol; 2010 Sep; 225(1):18-23. PubMed ID: 20044992
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
Lo AC; Black JA; Waxman SG
Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
Paintlia AS; Paintlia MK; Singh I; Skoff RB; Singh AK
Glia; 2009 Jan; 57(2):182-93. PubMed ID: 18720408
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection and neuroregeneration in multiple sclerosis.
Stangel M
J Neurol; 2008 Dec; 255 Suppl 6():77-81. PubMed ID: 19300964
[TBL] [Abstract][Full Text] [Related]
9. Axonal injury in multiple sclerosis.
Rammohan KW
Curr Neurol Neurosci Rep; 2003 May; 3(3):231-7. PubMed ID: 12691628
[TBL] [Abstract][Full Text] [Related]
10. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
11. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
12. Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.
Huang JK; Fancy SP; Zhao C; Rowitch DH; Ffrench-Constant C; Franklin RJ
Neurotherapeutics; 2011 Oct; 8(4):650-8. PubMed ID: 21904791
[TBL] [Abstract][Full Text] [Related]
13. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
14. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
[TBL] [Abstract][Full Text] [Related]
15. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in multiple sclerosis: a therapeutic approach.
Maghzi AH; Minagar A; Waubant E
CNS Drugs; 2013 Oct; 27(10):799-815. PubMed ID: 23955320
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
[TBL] [Abstract][Full Text] [Related]
18. Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine.
Kapoor R
J Neurol Sci; 2008 Nov; 274(1-2):54-6. PubMed ID: 18486153
[TBL] [Abstract][Full Text] [Related]
19. Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?
Dubessy AL; Zujovic V; Papeix C; Stankoff B
Rev Neurol (Paris); 2014 Dec; 170(12):770-8. PubMed ID: 25459127
[TBL] [Abstract][Full Text] [Related]
20. Promoting repair in multiple sclerosis: problems and prospects.
Lubetzki C; Williams A; Stankoff B
Curr Opin Neurol; 2005 Jun; 18(3):237-44. PubMed ID: 15891406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
